Drug-induced Cholestasis

Overview

Journal Hepatol Commun

Specialty Gastroenterology

Date 2018 Feb 7

PMID 29404489

Citations 40

Authors

Vinay Sundaram

Einar S Bjornsson

Affiliations

Soon will be listed here.

Abstract

Cholestatic drug-induced liver injury (DILI) can be a diagnostic challenge due to a large differential diagnosis, variability in clinical presentation, and lack of serologic biomarkers associated with this condition. The clinical presentation of drug-induced cholestasis includes bland cholestasis, cholestatic hepatitis, secondary sclerosing cholangitis, and vanishing bile duct syndrome. The associate mortality of cholestatic DILI can be as high as 10%, and thus prompt recognition and removal of the offending agent is of critical importance. Several risk factors have been identified for drug-induced cholestasis, including older age, genetic determinants, and properties of certain medications. Antibiotics, particularly amoxicillin/clavulanate, remain the predominant cause of cholestatic DILI, although a variety of other medications associated with this condition have been identified. In this review, we summarize the presentation, clinical approach, risk factors, implicated medications, and management of drug-induced cholestatic liver injury. ( 2017;1:726-735).

Citing Articles

Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review.

Vitale G, Sciveres M, Mandato C, dAdamo A, Di Giorgio A Orphanet J Rare Dis. 2025; 20(1):80.

PMID: 39984942 PMC: 11846186. DOI: 10.1186/s13023-025-03599-2.

Severe liver injury induced by minocycline in hepatitis B patient: a Case Report.

Wang R, Li Y, Xia X Front Pharmacol. 2025; 15:1516217.

PMID: 39749206 PMC: 11693611. DOI: 10.3389/fphar.2024.1516217.

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism.

Teka T, Wu J, Oduro P, Li Z, Wang C, Chen H Front Pharmacol. 2024; 15:1485035.

PMID: 39635428 PMC: 11614611. DOI: 10.3389/fphar.2024.1485035.

Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature.

Borgonovo E, De Cristofaro J, Aletti F, Pedica F, DAlessio A Cureus. 2024; 16(8):e68071.

PMID: 39347284 PMC: 11437016. DOI: 10.7759/cureus.68071.

Regular Consumption of Green Tea as an Element of Diet Therapy in Drug-Induced Liver Injury (DILI).

Winiarska-Mieczan A, Jachimowicz-Rogowska K, Kwiecien M, Borsuk-Stanulewicz M, Tomczyk-Warunek A, Stamirowska-Krzaczek E Nutrients. 2024; 16(17).

PMID: 39275155 PMC: 11396919. DOI: 10.3390/nu16172837.

References

Kleiner D, Chalasani N, Lee W, Fontana R, Bonkovsky H, Watkins P . Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2013; 59(2):661-70. PMC: 3946736. DOI: 10.1002/hep.26709. View

Fontana R, Shakil A, Greenson J, Boyd I, Lee W . Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci. 2005; 50(10):1785-90. DOI: 10.1007/s10620-005-2938-5. View

Gisbert J, Gonzalez-Lama Y, Mate J . Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2007; 102(7):1518-27. DOI: 10.1111/j.1572-0241.2007.01187.x. View

Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick G, Meier P . Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005; 43(2):342-57. DOI: 10.1016/j.jhep.2005.03.017. View

Devarbhavi H, Karanth D, Prasanna K, Adarsh C, Patil M . Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology. 2011; 54(4):1344-50. DOI: 10.1002/hep.24527. View

Lucena M, Andrade R, Kaplowitz N, Garcia-Cortes M, Fernandez M, Romero-Gomez M . Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009; 49(6):2001-9. DOI: 10.1002/hep.22895. View

Alqahtani S, Kleiner D, Ghabril M, Gu J, Hoofnagle J, Rockey D . Identification and Characterization of Cefazolin-Induced Liver Injury. Clin Gastroenterol Hepatol. 2014; 13(7):1328-1336.e2. PMC: 4472636. DOI: 10.1016/j.cgh.2014.11.036. View

Seto W, Ng M, Chan P, Ng I, Cheung S, Hung I . Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol. 2011; 106(5):1004-5. DOI: 10.1038/ajg.2010.485. View

Hautekeete M, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L . HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology. 1999; 117(5):1181-6. DOI: 10.1016/s0016-5085(99)70404-x. View

10.

Lucena M, Andrade R, Fernandez M, Pachkoria K, Pelaez G, Duran J . Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology. 2006; 44(4):850-6. DOI: 10.1002/hep.21324. View

11.

Nguyen K, Sundaram V, Ayoub W . Atypical causes of cholestasis. World J Gastroenterol. 2014; 20(28):9418-26. PMC: 4110573. DOI: 10.3748/wjg.v20.i28.9418. View

12.

Fairley C, McNeil J, Desmond P, Smallwood R, Young H, Forbes A . Risk factors for development of flucloxacillin associated jaundice. BMJ. 1993; 306(6872):233-5. PMC: 1676728. DOI: 10.1136/bmj.306.6872.233. View

13.

Ratnayake E, Shivanthan C, Wijesiriwardena B . Cholestatic hepatitis in a patient with typhoid fever - a case report. Ann Clin Microbiol Antimicrob. 2011; 10:35. PMC: 3200156. DOI: 10.1186/1476-0711-10-35. View

14.

Roda G, Caponi A, Belluzzi A, Roda E . Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis. Dig Liver Dis. 2009; 41(12):914-5. DOI: 10.1016/j.dld.2009.03.004. View

15.

Pauli-Magnus C, Meier P . Hepatobiliary transporters and drug-induced cholestasis. Hepatology. 2006; 44(4):778-87. DOI: 10.1002/hep.21359. View

16.

Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C . Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002; 36(2):451-5. DOI: 10.1053/jhep.2002.34857. View

17.

Srivastava M, Jonas M . Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology. 1998; 115(3):743-6. DOI: 10.1016/s0016-5085(98)70154-4. View

18.

Polson J . Hepatotoxicity due to antibiotics. Clin Liver Dis. 2007; 11(3):549-61, vi. DOI: 10.1016/j.cld.2007.06.009. View

19.

Danan G, Benichou C . Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993; 46(11):1323-30. DOI: 10.1016/0895-4356(93)90101-6. View

20.

Mainra R, Card S . Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome. Can J Clin Pharmacol. 2004; 10(4):175-8. View